Skip to content
10-Q

Quarterly Report

PharMerica CORP

0001388195-16-000038

← back to feed
Filed
Nov 9, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 2, 2016 30.78M sh
Long Term Debt Q3 2016 · Sep 30, 2016 $378.7M
Long Term Debt Q3 2016 · Dec 31, 2015 $413.6M
Short Term Debt Q3 2016 · Sep 30, 2016 $11.8M
Short Term Debt Q3 2016 · Dec 31, 2015 $11.6M
Stockholders Equity Q3 2016 · Sep 30, 2016 $535.8M
Stockholders Equity Q3 2016 · Dec 31, 2015 $519.4M
Current Liabilities Q3 2016 · Sep 30, 2016 $138.5M
Current Liabilities Q3 2016 · Dec 31, 2015 $141.4M
Current Assets Q3 2016 · Sep 30, 2016 $430M
Current Assets Q3 2016 · Dec 31, 2015 $483.5M
Total Assets Q3 2016 · Sep 30, 2016 $1.16B
Total Assets Q3 2016 · Dec 31, 2015 $1.15B
Shares Diluted Q3 2016 · Sep 30, 2015 30.9M sh
Shares Diluted Q3 2016 · Sep 30, 2015 30.8M sh
Capex Q3 2016 · Sep 30, 2015 $6.6M
Capex Q3 2016 · Sep 30, 2015 $17.6M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $40M
Cash And Equivalents Q3 2016 · Jun 30, 2015 $21.3M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $33.3M
Eps Diluted Q3 2016 · Sep 30, 2015 $0.10
Eps Diluted Q3 2016 · Sep 30, 2015 $0.48
Eps Basic Q3 2016 · Sep 30, 2015 $0.10
Eps Basic Q3 2016 · Sep 30, 2015 $0.49
Sga Expense Q3 2016 · Sep 30, 2015 $52.7M
Sga Expense Q3 2016 · Sep 30, 2015 $167.1M
Net Income Q3 2016 · Sep 30, 2015 $3M
Net Income Q3 2016 · Sep 30, 2015 $14.9M
Operating Income Q3 2016 · Sep 30, 2015 $8.5M
Operating Income Q3 2016 · Sep 30, 2015 $33.8M
Gross Profit Q3 2016 · Sep 30, 2015 $78.6M
Gross Profit Q3 2016 · Sep 30, 2015 $248.4M
Cost Of Revenue Q3 2016 · Sep 30, 2015 $420.2M
Cost Of Revenue Q3 2016 · Sep 30, 2015 $1.26B
Revenue Q3 2016 · Sep 30, 2015 $498.8M
Revenue Q3 2016 · Sep 30, 2015 $1.51B